img

Global Ocaliva Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Ocaliva Market Insights, Forecast to 2034

Obeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid.
Global Ocaliva market is expected to reach to US$ 278.1 million in 2024, with a positive growth of %, compared with US$ 309 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Ocaliva industry is evaluated to reach US$ 240.4 million in 2029. The CAGR will be -2.4% during 2024 to 2029.
The Ocaliva market is primarily driven by the urgent need for effective treatments for primary biliary cholangitis (PBC), a chronic liver disease that affects the bile ducts. Ocaliva, also known as obeticholic acid, is a medication used to manage PBC and improve liver function. The increasing prevalence of PBC, coupled with advancements in hepatology research and the focus on liver health, contributes to market growth. Moreover, the demonstrated benefits of Ocaliva in reducing serum alkaline phosphatase levels and delaying disease progression further propel adoption. However, challenges include managing potential side effects, optimizing dosing for individual patients, and addressing potential drug interactions. Navigating patient-specific treatment needs, ensuring long-term safety, and providing comprehensive monitoring are ongoing concerns. The market's success relies on continuous research in liver diseases, collaborations between pharmaceutical manufacturers and hepatologists, and comprehensive patient education on the benefits and potential risks of Ocaliva treatment while addressing the evolving challenges associated with liver disease management and treatment accessibility.
Report Covers
This report presents an overview of global Ocaliva market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Ocaliva market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Segment by Type
5mg
10mg

Segment by Application


Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Ocaliva plant distribution, commercial date of Ocaliva, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Ocaliva introduction, etc. Ocaliva Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Ocaliva
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Ocaliva Product Introduction
1.2 Market by Type
1.2.1 Global Ocaliva Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 5mg
1.2.3 10mg
1.3 Market by Application
1.3.1 Global Ocaliva Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Ocaliva Sales Estimates and Forecasts 2018-2029
2.2 Global Ocaliva Revenue by Region
2.2.1 Global Ocaliva Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Ocaliva Revenue by Region (2018-2024)
2.2.3 Global Ocaliva Revenue by Region (2024-2029)
2.2.4 Global Ocaliva Revenue Market Share by Region (2018-2029)
2.3 Global Ocaliva Sales Estimates and Forecasts 2018-2029
2.4 Global Ocaliva Sales by Region
2.4.1 Global Ocaliva Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Ocaliva Sales by Region (2018-2024)
2.4.3 Global Ocaliva Sales by Region (2024-2029)
2.4.4 Global Ocaliva Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Ocaliva Sales by Manufacturers
3.1.1 Global Ocaliva Sales by Manufacturers (2018-2024)
3.1.2 Global Ocaliva Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ocaliva in 2022
3.2 Global Ocaliva Revenue by Manufacturers
3.2.1 Global Ocaliva Revenue by Manufacturers (2018-2024)
3.2.2 Global Ocaliva Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Ocaliva Revenue in 2022
3.3 Global Key Players of Ocaliva, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Ocaliva Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Ocaliva Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Ocaliva, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Ocaliva, Product Offered and Application
3.8 Global Key Manufacturers of Ocaliva, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ocaliva Sales by Type
4.1.1 Global Ocaliva Historical Sales by Type (2018-2024)
4.1.2 Global Ocaliva Forecasted Sales by Type (2024-2029)
4.1.3 Global Ocaliva Sales Market Share by Type (2018-2029)
4.2 Global Ocaliva Revenue by Type
4.2.1 Global Ocaliva Historical Revenue by Type (2018-2024)
4.2.2 Global Ocaliva Forecasted Revenue by Type (2024-2029)
4.2.3 Global Ocaliva Revenue Market Share by Type (2018-2029)
4.3 Global Ocaliva Price by Type
4.3.1 Global Ocaliva Price by Type (2018-2024)
4.3.2 Global Ocaliva Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Ocaliva Sales by Application
5.1.1 Global Ocaliva Historical Sales by Application (2018-2024)
5.1.2 Global Ocaliva Forecasted Sales by Application (2024-2029)
5.1.3 Global Ocaliva Sales Market Share by Application (2018-2029)
5.2 Global Ocaliva Revenue by Application
5.2.1 Global Ocaliva Historical Revenue by Application (2018-2024)
5.2.2 Global Ocaliva Forecasted Revenue by Application (2024-2029)
5.2.3 Global Ocaliva Revenue Market Share by Application (2018-2029)
5.3 Global Ocaliva Price by Application
5.3.1 Global Ocaliva Price by Application (2018-2024)
5.3.2 Global Ocaliva Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Ocaliva Market Size by Type
6.1.1 US & Canada Ocaliva Sales by Type (2018-2029)
6.1.2 US & Canada Ocaliva Revenue by Type (2018-2029)
6.2 US & Canada Ocaliva Market Size by Application
6.2.1 US & Canada Ocaliva Sales by Application (2018-2029)
6.2.2 US & Canada Ocaliva Revenue by Application (2018-2029)
6.3 US & Canada Ocaliva Market Size by Country
6.3.1 US & Canada Ocaliva Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Ocaliva Sales by Country (2018-2029)
6.3.3 US & Canada Ocaliva Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Ocaliva Market Size by Type
7.1.1 Europe Ocaliva Sales by Type (2018-2029)
7.1.2 Europe Ocaliva Revenue by Type (2018-2029)
7.2 Europe Ocaliva Market Size by Application
7.2.1 Europe Ocaliva Sales by Application (2018-2029)
7.2.2 Europe Ocaliva Revenue by Application (2018-2029)
7.3 Europe Ocaliva Market Size by Country
7.3.1 Europe Ocaliva Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Ocaliva Sales by Country (2018-2029)
7.3.3 Europe Ocaliva Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Ocaliva Market Size
8.1.1 China Ocaliva Sales (2018-2029)
8.1.2 China Ocaliva Revenue (2018-2029)
8.2 China Ocaliva Market Size by Application
8.2.1 China Ocaliva Sales by Application (2018-2029)
8.2.2 China Ocaliva Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Ocaliva Market Size by Type
9.1.1 Asia Ocaliva Sales by Type (2018-2029)
9.1.2 Asia Ocaliva Revenue by Type (2018-2029)
9.2 Asia Ocaliva Market Size by Application
9.2.1 Asia Ocaliva Sales by Application (2018-2029)
9.2.2 Asia Ocaliva Revenue by Application (2018-2029)
9.3 Asia Ocaliva Sales by Region
9.3.1 Asia Ocaliva Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Ocaliva Revenue by Region (2018-2029)
9.3.3 Asia Ocaliva Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Ocaliva Market Size by Type
10.1.1 Middle East, Africa and Latin America Ocaliva Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Ocaliva Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Ocaliva Market Size by Application
10.2.1 Middle East, Africa and Latin America Ocaliva Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Ocaliva Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Ocaliva Sales by Country
10.3.1 Middle East, Africa and Latin America Ocaliva Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Ocaliva Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Ocaliva Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Intercept Pharmaceuticals
11.1.1 Intercept Pharmaceuticals Company Information
11.1.2 Intercept Pharmaceuticals Overview
11.1.3 Intercept Pharmaceuticals Ocaliva Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Intercept Pharmaceuticals Ocaliva Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Intercept Pharmaceuticals Recent Developments
11.2 Dainippon Sumitomo Pharma
11.2.1 Dainippon Sumitomo Pharma Company Information
11.2.2 Dainippon Sumitomo Pharma Overview
11.2.3 Dainippon Sumitomo Pharma Ocaliva Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Dainippon Sumitomo Pharma Ocaliva Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Dainippon Sumitomo Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ocaliva Industry Chain Analysis
12.2 Ocaliva Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ocaliva Production Mode & Process
12.4 Ocaliva Sales and Marketing
12.4.1 Ocaliva Sales Channels
12.4.2 Ocaliva Distributors
12.5 Ocaliva Customers
13 Market Dynamics
13.1 Ocaliva Industry Trends
13.2 Ocaliva Market Drivers
13.3 Ocaliva Market Challenges
13.4 Ocaliva Market Restraints
14 Key Findings in The Global Ocaliva Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Ocaliva Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 5mg
Table 3. Major Manufacturers of 10mg
Table 4. Global Ocaliva Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Ocaliva Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Ocaliva Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Ocaliva Revenue Market Share by Region (2018-2024)
Table 9. Global Ocaliva Revenue Market Share by Region (2024-2029)
Table 10. Global Ocaliva Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Ocaliva Sales by Region (2018-2024) & (K Units)
Table 12. Global Ocaliva Sales by Region (2024-2029) & (K Units)
Table 13. Global Ocaliva Sales Market Share by Region (2018-2024)
Table 14. Global Ocaliva Sales Market Share by Region (2024-2029)
Table 15. Global Ocaliva Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Ocaliva Sales Share by Manufacturers (2018-2024)
Table 17. Global Ocaliva Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Ocaliva Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Ocaliva, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Ocaliva Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Ocaliva Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Ocaliva by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ocaliva as of 2022)
Table 23. Global Key Manufacturers of Ocaliva, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Ocaliva, Product Offered and Application
Table 25. Global Key Manufacturers of Ocaliva, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Ocaliva Sales by Type (2018-2024) & (K Units)
Table 28. Global Ocaliva Sales by Type (2024-2029) & (K Units)
Table 29. Global Ocaliva Sales Share by Type (2018-2024)
Table 30. Global Ocaliva Sales Share by Type (2024-2029)
Table 31. Global Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Ocaliva Revenue Share by Type (2018-2024)
Table 34. Global Ocaliva Revenue Share by Type (2024-2029)
Table 35. Ocaliva Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Ocaliva Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Ocaliva Sales by Application (2018-2024) & (K Units)
Table 38. Global Ocaliva Sales by Application (2024-2029) & (K Units)
Table 39. Global Ocaliva Sales Share by Application (2018-2024)
Table 40. Global Ocaliva Sales Share by Application (2024-2029)
Table 41. Global Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Ocaliva Revenue Share by Application (2018-2024)
Table 44. Global Ocaliva Revenue Share by Application (2024-2029)
Table 45. Ocaliva Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Ocaliva Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Ocaliva Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Ocaliva Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Ocaliva Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Ocaliva Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Ocaliva Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Ocaliva Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Ocaliva Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Ocaliva Sales by Country (2024-2029) & (K Units)
Table 60. Europe Ocaliva Sales by Type (2018-2024) & (K Units)
Table 61. Europe Ocaliva Sales by Type (2024-2029) & (K Units)
Table 62. Europe Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Ocaliva Sales by Application (2018-2024) & (K Units)
Table 65. Europe Ocaliva Sales by Application (2024-2029) & (K Units)
Table 66. Europe Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Ocaliva Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Ocaliva Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Ocaliva Sales by Country (2018-2024) & (K Units)
Table 72. Europe Ocaliva Sales by Country (2024-2029) & (K Units)
Table 73. China Ocaliva Sales by Type (2018-2024) & (K Units)
Table 74. China Ocaliva Sales by Type (2024-2029) & (K Units)
Table 75. China Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Ocaliva Sales by Application (2018-2024) & (K Units)
Table 78. China Ocaliva Sales by Application (2024-2029) & (K Units)
Table 79. China Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Ocaliva Sales by Type (2018-2024) & (K Units)
Table 82. Asia Ocaliva Sales by Type (2024-2029) & (K Units)
Table 83. Asia Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Ocaliva Sales by Application (2018-2024) & (K Units)
Table 86. Asia Ocaliva Sales by Application (2024-2029) & (K Units)
Table 87. Asia Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Ocaliva Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Ocaliva Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Ocaliva Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Ocaliva Sales by Region (2018-2024) & (K Units)
Table 93. Asia Ocaliva Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Ocaliva Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Ocaliva Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Ocaliva Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Ocaliva Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Ocaliva Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Ocaliva Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Ocaliva Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Ocaliva Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Ocaliva Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Ocaliva Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Ocaliva Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Ocaliva Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Ocaliva Sales by Country (2024-2029) & (K Units)
Table 107. Intercept Pharmaceuticals Company Information
Table 108. Intercept Pharmaceuticals Description and Major Businesses
Table 109. Intercept Pharmaceuticals Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Intercept Pharmaceuticals Ocaliva Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Intercept Pharmaceuticals Recent Developments
Table 112. Dainippon Sumitomo Pharma Company Information
Table 113. Dainippon Sumitomo Pharma Description and Major Businesses
Table 114. Dainippon Sumitomo Pharma Ocaliva Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Dainippon Sumitomo Pharma Ocaliva Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Dainippon Sumitomo Pharma Recent Developments
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Ocaliva Distributors List
Table 120. Ocaliva Customers List
Table 121. Ocaliva Market Trends
Table 122. Ocaliva Market Drivers
Table 123. Ocaliva Market Challenges
Table 124. Ocaliva Market Restraints
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Ocaliva Product Picture
Figure 2. Global Ocaliva Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Ocaliva Market Share by Type in 2022 & 2029
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Ocaliva Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Ocaliva Market Share by Application in 2022 & 2029
Figure 8. Primary Biliary Cirrhosis
Figure 9. Nonalcoholic Fatty Liver Disease
Figure 10. Other
Figure 11. Ocaliva Report Years Considered
Figure 12. Global Ocaliva Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Ocaliva Revenue 2018-2029 (US$ Million)
Figure 14. Global Ocaliva Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Ocaliva Revenue Market Share by Region (2018-2029)
Figure 16. Global Ocaliva Sales 2018-2029 ((K Units)
Figure 17. Global Ocaliva Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Ocaliva Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Ocaliva Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Ocaliva Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Ocaliva Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Ocaliva Sales YoY (2018-2029) & (K Units)
Figure 23. China Ocaliva Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Ocaliva Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Ocaliva Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Ocaliva Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Ocaliva Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Ocaliva Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Ocaliva in the World: Market Share by Ocaliva Revenue in 2022
Figure 30. Global Ocaliva Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Ocaliva Sales Market Share by Type (2018-2029)
Figure 32. Global Ocaliva Revenue Market Share by Type (2018-2029)
Figure 33. Global Ocaliva Sales Market Share by Application (2018-2029)
Figure 34. Global Ocaliva Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Ocaliva Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Ocaliva Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Ocaliva Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Ocaliva Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Ocaliva Revenue Share by Country (2018-2029)
Figure 40. US & Canada Ocaliva Sales Share by Country (2018-2029)
Figure 41. U.S. Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Ocaliva Sales Market Share by Type (2018-2029)
Figure 44. Europe Ocaliva Revenue Market Share by Type (2018-2029)
Figure 45. Europe Ocaliva Sales Market Share by Application (2018-2029)
Figure 46. Europe Ocaliva Revenue Market Share by Application (2018-2029)
Figure 47. Europe Ocaliva Revenue Share by Country (2018-2029)
Figure 48. Europe Ocaliva Sales Share by Country (2018-2029)
Figure 49. Germany Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 50. France Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 54. China Ocaliva Sales Market Share by Type (2018-2029)
Figure 55. China Ocaliva Revenue Market Share by Type (2018-2029)
Figure 56. China Ocaliva Sales Market Share by Application (2018-2029)
Figure 57. China Ocaliva Revenue Market Share by Application (2018-2029)
Figure 58. Asia Ocaliva Sales Market Share by Type (2018-2029)
Figure 59. Asia Ocaliva Revenue Market Share by Type (2018-2029)
Figure 60. Asia Ocaliva Sales Market Share by Application (2018-2029)
Figure 61. Asia Ocaliva Revenue Market Share by Application (2018-2029)
Figure 62. Asia Ocaliva Revenue Share by Region (2018-2029)
Figure 63. Asia Ocaliva Sales Share by Region (2018-2029)
Figure 64. Japan Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 68. India Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Ocaliva Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Ocaliva Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Ocaliva Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Ocaliva Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Ocaliva Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Ocaliva Sales Share by Country (2018-2029)
Figure 75. Brazil Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Ocaliva Revenue (2018-2029) & (US$ Million)
Figure 80. Ocaliva Value Chain
Figure 81. Ocaliva Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed